CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health elevance Health (ELV) — Benefit Expense ($M)
Annual figures from Cvs Health's filings and investor materials
Latest, FY2025
148,223
Period ended Dec 31, 2025
Change on a year earlier
+16.2%
127,567 in FY2024
History
10 years
Since FY2016
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Elevance Health (ELV) — Benefit Expense ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 148,223 | +16.2% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 127,567 | +2.6% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 124,330 | +6.6% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 116,642 | +13.7% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 102,571 | +16.5% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 88,045 | +7.7% | Elevance Health, Inc. SEC 10-Q (XBRL) ↗ |
| FY2019 | Dec 31, 2019 | 81,786 | +13.8% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2018 | Dec 31, 2018 | 71,895 | -0.5% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2017 | Dec 31, 2017 | 72,236 | +8.1% | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
| FY2016 | Dec 31, 2016 | 66,834 | – | Elevance Health, Inc. SEC 10-K (XBRL) ↗ |
Cite this data
StockData. (2026). Cvs Health Elevance Health (ELV) — Benefit Expense ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_elv_benefits
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.